FindTrial
Sign In

Relationship between atrial heart disease and residual shunt after migraine in patients with patent foramen ovale

Relationship between atrial heart disease and residual shunt after migraine in patients with patent foramen ovale

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093371
Enrollment
Unknown
Registered
2024-12-03
Start date
2024-12-03
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patent foramen ovale

Interventions

Atrial cardiomyopathy group:None
Non-Atrial cardiomyopathy group:None

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Severe migraine diagnosed with right-to-left shunt (RLS) (Grade II-IV) 2. Undergo PFO surgery 3. Symptoms did not improve after receiving migraine medication 4. Less traditional cardiovascular risk factors (e.g., hypertension, diabetes, hyperlipidemia, smoking)

Exclusion criteria

Exclusion criteria: 1. Exclude other migraines caused by diffuse cortical inhibition, infection, neuropeptide action, genetics, etc

Design outcomes

Primary

MeasureTime frame
Cardiovascular rehospitalization;Cardiovascular death;—

Countries

China

Contacts

Public ContactXin Gao

The First Affiliated Hospital of Dalian Medical University

18098875802@163.com+86 180 9887 5802

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026